PCI Biotech: Fourth quarter 2012 and preliminary 2012 results

February 05, 2013 01:30 ET | Source: PCI Biotech Holding ASA PCI Biotech Holding ASA

Oslo, Norway, 5 February 2013.

Please find attached the presentation and report for Q4 2012 and preliminary full year 2012.

The presentation will be held the 5 February at 0800 at Felix Konferansesenter.

Kind regards,

Per Walday
CEO

Email: pw@pcibiotech.no
Mobil: +47 917 93 429

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Attachments

PCI Biotech Q4 2012 Presentation...

PCI Biotech Q4 2012 Report...

Recommended Reading

January 29, 2026 11:50 ET | Source: PCI Biotech Holding ASA

PCI Biotech initiates a process to evaluate the opportunity for a structured wind-up process

Oslo (Norway), 29 January 2026 – PCI Biotech (OSE: PCIB) refers to its latest announcement of 8 January 2026 regarding the discontinuation of all R&D operations and the continued exploration of...
Read More
January 08, 2026 08:10 ET | Source: PCI Biotech Holding ASA

PCI Biotech announces discontinuation of R&D operations and continues evaluation of future options

Oslo (Norway), 8 January 2026 – PCI Biotech (OSE: PCIB). Reference is made to the company’s latest announcement dated 23rd October 2025. The external evaluation of a new bioprocessing technology has...
Read More